ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
LGND,LIGAND PHARMACEUTICALS INC,53220K504,96517000.0,3621665,16.094267447948802,2013-05-15,2013-03-31,0000921895-13-001111
IRWD,IRONWOOD PHARMACEUTICALS INC,46333X108,96043000.0,5252561,16.015227664591176,2013-05-15,2013-03-31,0000921895-13-001111
CCXIEUR,CHEMOCENTRYX INC,16383L106,69470000.0,5026766,11.584164029228045,2013-05-15,2013-03-31,0000921895-13-001111
N/A,RIGEL PHARMACEUTICALS INC,766559603,59059000.0,8697997,9.848123555522946,2013-05-15,2013-03-31,0000921895-13-001111
ARRYEUR,ARRAY BIOPHARMA INC,04269X105,56245000.0,11431858,9.378887373311233,2013-05-15,2013-03-31,0000921895-13-001111
AMGN,AMGEN INC,031162100,51255000.0,500000,8.546801890284776,2013-05-15,2013-03-31,0000921895-13-001111
N/A,TARGACEPT INC,87611R306,26415000.0,6171669,4.404717040910592,2013-05-15,2013-03-31,0000921895-13-001111
N/A,QLT INC,746927102,24092000.0,2725303,4.017355402219117,2013-05-15,2013-03-31,0000921895-13-001111
EXEL 4.25 08/15/19,EXELIXIS INC,30161QAC8,18412000.0,18435000,3.070212006710044,2013-05-15,2013-03-31,0000921895-13-001111
N/A,REGULUS THERAPEUTICS INC,75915K101,15109000.0,1949563,2.519434782173694,2013-05-15,2013-03-31,0000921895-13-001111
N/A,CYTOKINETICS INC,23282W100,11757000.0,10313435,1.9604867783451003,2013-05-15,2013-03-31,0000921895-13-001111
N/A,PAIN THERAPEUTICS INC,69562K100,11173000.0,3257327,1.863104429229379,2013-05-15,2013-03-31,0000921895-13-001111
EXEL,8/1 EXELIXIS INC,30161Q104,10132000.0,2193000,1.689517056918649,2013-05-15,2013-03-31,0000921895-13-001111
N/A,ISIS PHARMACEUTICALS INC,464330109,9776000.0,577100,1.6301538441015313,2013-05-15,2013-03-31,0000921895-13-001111
N/A,ONCOTHYREON INC,682324108,7450000.0,3581914,1.2422919536166537,2013-05-15,2013-03-31,0000921895-13-001111
ARQLUSD,ARQULE INC,04269E107,6818000.0,2632432,1.1369055758064894,2013-05-15,2013-03-31,0000921895-13-001111
N/A,ENDOCYTE INC,29269A102,6127000.0,492100,1.0216809127260722,2013-05-15,2013-03-31,0000921895-13-001111
VNDA,VANDA PHARMACEUTICALS INC,921659108,4451000.0,1135444,0.7422069108117753,2013-05-15,2013-03-31,0000921895-13-001111
N/A,PALATIN TECHNOLOGIES INC,696077403,3120000.0,5200000,0.5202618651387866,2013-05-15,2013-03-31,0000921895-13-001111
ACAD,ACADIA PHARMACEUTICALS INC,004225108,3119000.0,392870,0.5200951145409857,2013-05-15,2013-03-31,0000921895-13-001111
N/A,ANTHERA PHARMACEUTICALS INC,03674U102,2955000.0,4477000,0.4927480165016392,2013-05-15,2013-03-31,0000921895-13-001111
N/A,AVANIR PHARMACEUTICALS INC,05348P401,2149000.0,781700,0.3583470346741193,2013-05-15,2013-03-31,0000921895-13-001111
N/A,CAPSTONE THERAPEUTICS CORP,14068E109,1784000.0,7755688,0.29748306647679335,2013-05-15,2013-03-31,0000921895-13-001111
N/A,GENVEC INC,37246C307,1686000.0,1116600,0.2811415078923058,2013-05-15,2013-03-31,0000921895-13-001111
DRRXEUR,DURECT CORP,266605104,1469000.0,1104763,0.24495662816951197,2013-05-15,2013-03-31,0000921895-13-001111
N/A,FLAMEL TECHNOLOGIES SA,338488109,957000.0,216581,0.15958032209545472,2013-05-15,2013-03-31,0000921895-13-001111
N/A,ASTEX PHARMACEUTICALS INC,04624B103,828000.0,185600,0.1380694949791395,2013-05-15,2013-03-31,0000921895-13-001111
N/A,TRANSCEPT PHARMACEUTICALS IN,89354M106,719000.0,150000,0.11989367981884215,2013-05-15,2013-03-31,0000921895-13-001111
N/A,CADUS CORP,127639102,380000.0,269270,0.06336522716433939,2013-05-15,2013-03-31,0000921895-13-001111
MYRX,MYREXIS INC,62856H107,159000.0,1673486,0.02651334505034201,2013-05-15,2013-03-31,0000921895-13-001111
N/A,NEUROGESX,641252101,72000.0,1196191,0.012006043041664305,2013-05-15,2013-03-31,0000921895-13-001111
